Filing Details

Accession Number:
0001610717-23-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-15 16:37:41
Reporting Period:
2023-05-11
Accepted Time:
2023-05-15 16:37:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770787 10X Genomics Inc. TXG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1421050 Mathai Mammen C/O 10X Genomics, Inc.
6230 Stoneridge Mall Road
Pleasanton CA 94588
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2023-05-11 200,000 $1.16 202,745 No 4 M Direct
Class A Common Stock Disposition 2023-05-11 33,000 $52.82 169,745 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (right to buy) Disposition 2023-05-11 200,000 $0.00 200,000 $1.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-06-12 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $52.43 to $53.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  2. All of the shares subject to the option are fully vested and exercisable as of the date hereof.